Expression Patterns of DLL3 Across Neuroendocrine and Non-Neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting.
Lozada JR, Elliott A, Evans MG, Wacker J, Storey KM, Egusa EA, Zorko NA, Kumar A, Crymes A, Heath EI, Carneiro BA, Soares HP, Cichocki F, Miller JS, Lou E, Beltran H, Antonarakis ES, Ryan CJ, Hwang JH.
Lozada JR, et al. Among authors: kumar a.
Cancer Res Commun. 2025 Jan 28. doi: 10.1158/2767-9764.CRC-24-0501. Online ahead of print.
Cancer Res Commun. 2025.
PMID: 39874041